These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31029606)

  • 1. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis.
    Seidl E; Kiermeier H; Liebisch G; Ballmann M; Hesse S; Paul-Buck K; Ratjen F; Rietschel E; Griese M
    J Cyst Fibros; 2019 Nov; 18(6):790-795. PubMed ID: 31029606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease.
    de Vries JJV; Chang AB; Marchant JM
    Pediatr Pulmonol; 2018 Apr; 53(4):467-474. PubMed ID: 29405664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.
    Scholte BJ; Horati H; Veltman M; Vreeken RJ; Garratt LW; Tiddens HAWM; Janssens HM; Stick SM;
    J Cyst Fibros; 2019 Nov; 18(6):781-789. PubMed ID: 31031161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
    Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
    Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients.
    Ma DC; Yoon AJ; Faull KF; Desharnais R; Zemanick ET; Porter E
    PLoS One; 2015; 10(4):e0125326. PubMed ID: 25919295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant lipidomics in healthy children and childhood interstitial lung disease.
    Griese M; Kirmeier HG; Liebisch G; Rauch D; Stückler F; Schmitz G; Zarbock R;
    PLoS One; 2015; 10(2):e0117985. PubMed ID: 25692779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug.
    Gunasekara L; Al-Saiedy M; Green F; Pratt R; Bjornson C; Yang A; Michael Schoel W; Mitchell I; Brindle M; Montgomery M; Keys E; Dennis J; Shrestha G; Amrein M
    J Cyst Fibros; 2017 Sep; 16(5):565-572. PubMed ID: 28599957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis.
    Regamey N; Tsartsali L; Hilliard TN; Fuchs O; Tan HL; Zhu J; Qiu YS; Alton EW; Jeffery PK; Bush A; Davies JC
    Thorax; 2012 Feb; 67(2):164-70. PubMed ID: 22008188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Lipidomics in Pulmonary Alveolar Proteinosis.
    Griese M; Bonella F; Costabel U; de Blic J; Tran NB; Liebisch G
    Am J Respir Crit Care Med; 2019 Oct; 200(7):881-887. PubMed ID: 31002528
    [No Abstract]   [Full Text] [Related]  

  • 10. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
    Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
    Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary surfactant in cystic fibrosis.
    Griese M; Birrer P; Demirsoy A
    Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and composition of pulmonary surfactant and surfactant-derived fatty acid profiles are altered in young adults with cystic fibrosis.
    Meyer KC; Sharma A; Brown R; Weatherly M; Moya FR; Lewandoski J; Zimmerman JJ
    Chest; 2000 Jul; 118(1):164-74. PubMed ID: 10893374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs.
    Keiser NW; Birket SE; Evans IA; Tyler SR; Crooke AK; Sun X; Zhou W; Nellis JR; Stroebele EK; Chu KK; Tearney GJ; Stevens MJ; Harris JK; Rowe SM; Engelhardt JF
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):683-94. PubMed ID: 25317669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and subtyping of biofilms present in bronchoalveolar lavage from children with protracted bacterial bronchitis or non-cystic fibrosis bronchiectasis: a cross-sectional study.
    Marsh RL; Binks MJ; Smith-Vaughan HC; Janka M; Clark S; Richmond P; Chang AB; Thornton RB
    Lancet Microbe; 2022 Mar; 3(3):e215-e223. PubMed ID: 35544075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
    Ratjen F; Rietschel E; Griese M; Ballmann M; Kleinau I; Döring G; Reinhardt D; Paul K
    Eur Respir J; 2000 Jan; 15(1):141-5. PubMed ID: 10678636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel neutrophil-derived proteins in bronchoalveolar lavage fluid indicate an exaggerated inflammatory response in pediatric cystic fibrosis patients.
    McMorran BJ; Patat SA; Carlin JB; Grimwood K; Jones A; Armstrong DS; Galati JC; Cooper PJ; Byrnes CA; Francis PW; Robertson CF; Hume DA; Borchers CH; Wainwright CE; Wainwright BJ
    Clin Chem; 2007 Oct; 53(10):1782-91. PubMed ID: 17702859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal pro-gly-pro pathway and airway neutrophilia in pediatric cystic fibrosis.
    Turnbull AR; Pyle CJ; Patel DF; Jackson PL; Hilliard TN; Regamey N; Tan HL; Brown S; Thursfield R; Short C; Mc Fie M; Alton EWFW; Gaggar A; Blalock JE; Lloyd CM; Bush A; Davies JC; Snelgrove RJ
    J Cyst Fibros; 2020 Jan; 19(1):40-48. PubMed ID: 31176670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective assessment of protracted bacterial bronchitis: airway inflammation and innate immune activation.
    Marchant JM; Gibson PG; Grissell TV; Timmins NL; Masters IB; Chang AB
    Pediatr Pulmonol; 2008 Nov; 43(11):1092-1099. PubMed ID: 18846558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Respiratory Microbiota Profiles Are Associated With Lower Airway Inflammation in Children With Protracted Bacterial Bronchitis.
    Marsh RL; Smith-Vaughan HC; Chen ACH; Marchant JM; Yerkovich ST; Gibson PG; Pizzutto SJ; Hodge S; Upham JW; Chang AB
    Chest; 2019 Apr; 155(4):778-786. PubMed ID: 30660785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.